ValuEngine lowered shares of Cyanotech Corporation (NASDAQ:CYAN) from a hold rating to a sell rating in a research note issued to investors on Friday morning.

Separately, TheStreet upgraded Cyanotech Corporation from a d rating to a c- rating in a research report on Monday, August 28th.

Shares of Cyanotech Corporation (CYAN) traded up $0.11 during midday trading on Friday, hitting $4.35. The stock had a trading volume of 4,100 shares, compared to its average volume of 6,460. The stock has a market capitalization of $24.99, a PE ratio of 72.50 and a beta of 1.13. Cyanotech Corporation has a one year low of $3.25 and a one year high of $5.35. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.79 and a current ratio of 2.36.

Cyanotech Corporation (NASDAQ:CYAN) last announced its quarterly earnings results on Monday, November 6th. The biotechnology company reported $0.08 earnings per share for the quarter. The company had revenue of $8.06 million during the quarter. Cyanotech Corporation had a return on equity of 2.06% and a net margin of 1.11%.

ILLEGAL ACTIVITY NOTICE: This story was originally published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another website, it was copied illegally and reposted in violation of United States & international trademark and copyright legislation. The original version of this story can be accessed at

About Cyanotech Corporation

Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.

Receive News & Ratings for Cyanotech Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.